Related Experiment Video
Updated: Aug 4, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Surgery in active infective endocarditis
Insights
Early surgery for severe infective endocarditis (IE) may improve outcomes. Aggressive surgical intervention for IE patients with valve dysfunction and heart failure is justified, as survivors show infection eradication and minimal complications.
Area of Science:
- Cardiology
- Infectious Diseases
- Cardiac Surgery
Background:
- The optimal timing for surgical intervention in severe infective endocarditis (IE) remains debated.
- High mortality rates are associated with both medical and surgical management of IE.
Purpose of the Study:
- To evaluate the outcomes of early surgical intervention in patients with severe infective endocarditis.
- To determine if aggressive surgical management impacts mortality and postoperative complications in active IE.
Main Methods:
- Retrospective review of 163 infective endocarditis episodes.
- Analysis of 32 cardiac operations performed during active IE.
- Comparison of surgical versus medical mortality rates and postoperative complications.
Main Results:
- Surgical mortality (37%) did not differ significantly from medical mortality (20%).
- Congestive heart failure was the primary indication for surgery (88%).
- Survivors of surgery experienced rare postoperative complications, including infection eradication.
Conclusions:
- Delayed surgical intervention may contribute to high surgical mortality in IE.
- An aggressive surgical approach is warranted for IE patients with valve dysfunction and heart failure.
- Surgical intervention in active IE can lead to successful infection eradication and favorable outcomes in survivors.
Abstract:
Controversy persists concerning the role of early surgical intervention in severe infective endocarditis (IE). We therefore reviewed 163 episodes of well-documented IE in which 32 cardiac operations were performed during the active phase of IE. Congestive heart failure (CHF) was the principal indication for surgery in 88% (28/32); systemic emboli, 1/32; and persisting sepsis, 3/32. Staphylococcus and enterococcus were the most common infecting organisms in the operative group (44% and 16% respectively). Surgical mortality (11/32,37%) did not differ (p greater than 0.05) from medical mortality (26/131,20%). All 11 operative deaths occurred in patients moribund prior to surgery, including three with preoperative cardiac arrest. Surgical patients undergoing preoperative cardiac catheterization demonstrated marked CHF: a mean left ventricular end-diastolic pressure of 25.3 mm Hg. The mean cardiac index in 8/11 surgical deaths was lower (p less than 0.05) vs surgical survivors: 2.21/min/m2 vs. 3.21/min/m2. Postoperative complications were rare in the 21 surgical survivors. There were no episodes of continued infection, prosthetic dehiscence, or advanced heart block; only one paravalvular leak; and one systemic embolus. These findings emphasize the high medical and surgical mortality in patients with IE, suggest that delayed operative intervention may be a major causative factor resulting in a high surgical mortality, and justify an aggressive surgical approach in patients with valve dysfunction and heart failure. These data indicate that survivors of surgical intervention during active IE have eradication of infection and few postoperative complications.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care

